Ovarian cancer–can intraperitoneal therapy be regarded as new standard in Germany?

TitleOvarian cancer–can intraperitoneal therapy be regarded as new standard in Germany?
Publication TypeJournal Article
Year of Publication2006
Authorsdu Bois, A, Schmalfeldt, B, Meier, W, Sehouli, J, Pfisterer, J, OVAR, AGynaekolog, Cancer, AGOStudy Grou, Onkologie, NGesellscha
JournalInt J Gynecol Cancer
Volume16
Pagination1756-60
KeywordsAntineoplastic Agents/*administration & dosage/adverse effects Clinical Trials as Topic Female Germany Humans Infusions, Parenteral/*methods Ovarian Neoplasms/*drug therapy Practice Guidelines as Topic
Abstract

The German Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) and the two German cooperative study groups (AGO-OVAR and NOGGO) performed a review of the currently available literature on intraperitoneal first-line treatment in advanced ovarian cancer to consider if this new option should be incorporated into the German guidelines for treatment of ovarian cancer.